A high-abundant protein in the HQ-treated MCF-7 cells, RPS5, acts as a tumor suppressor by regulating TP53 and c-myc, and its deficiency is associated with tumor progression and aggressiveness (Fancello et al., 2017). Here, RPS5 is linked to neoplasm.